Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-015031

Options or other derivatives

  • Director acquired 23,345 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Jayne David R.W. Director 2022-05-18 Grant or award · Restricted Stock Unit +8,733 8,733 D
Jayne David R.W. Director 2022-05-18 Grant or award · Stock Option (right to buy) +14,612 14,612 D
Loading xslF345X03/wf-form4_165307729475114.xml…